Nadir Koçak

Nadir Koçak

Auto-generated profile, based on publicly available information

Nadir Koçak

Department of Medical Genetics, Faculty of Medicine, Selcuk University, Konya, Turkey

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2022 in Investigational New Drugs
Verified
Journal Article
Closed access
PDF file
KTKubra Sena Bas Topcu
Kubra Sena Bas Topcu
EKEmine Nedime Korucu
Emine Nedime Korucu
EMESMA MENEVSE
ESMA MENEVSE
NKNadir Kocak
Nadir Kocak
TDTugce Duran
Tugce Duran

29 March 2024 in Cukurova Medical Journal
Verified
Journal Article
Open access
PDF file
TDTuğçe Duran
Tuğçe Duran
NKNadir Koçak
Nadir Koçak
MKMehmet Ali Karaselek
Mehmet Ali Karaselek
Purpose: This study aimed to evaluate the possible anticancer and apoptotic effect of carnosol and carnosic acid on non-small cell lung cancer (NSCLC) cell lines in vitro. Materials and Methods: Three different NSCLC cell lines (H441, H520, and H661) were used in the study and treatment (carnosol and carnosic acid treatment) and control (no treatment) groups were established in all cell lines. The IC50 doses were determined by MTT method on NSCLC cell lines and the changes in expression levels of apoptosis-related genes (Bax, Bak, caspase-3, p53, c-Myc, Bcl-2, and Bcl-XL) were demonstrated by real-time polymerase chain reaction (qPCR), and apoptosis was confirmed by flow cytometry. The treatment group and control group results were compared. Results: The IC50 doses of carnosol and carnosic acid were determined; 60 µM for the H441, 20 µM for the H661, 40 µM for the H520, 20 µM for the H441, 40 µM for the H661, 40 µM for the H520, respectively. Carnosol treatment increased Bax, Bak, caspase-3, and p53 expression but decreased Bcl-XL expression in studied lung cancer cell lines. Carnosic acid treatment increased apoptotic Bax, Bak, caspase-3, and p53 expression but decreased antiapoptotic Bcl-2 and Bcl-XL expression (p

1 January 2024 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
NMNigar Mammadova
Nigar Mammadova
SÖSibel Özler
Sibel Özler
BÖBelma Gözde Özdemir
Belma Gözde Özdemir
FAFazıl Avcı
Fazıl Avcı
NKNadir Koçak
Nadir Koçak
ÇÇÇetin Çelik
Çetin Çelik
The aim of this study was to investigate the relationship between Chitinase 3-Like 1 gene polymorphisms and the occurrence of preeclampsia in a selected cohort of pregnant women.

30 September 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TDTugce Duran
Tugce Duran
NCNaci Cine
Naci Cine
MKMehmet Ali Karaselek
Mehmet Ali Karaselek
NGNadir Gul
Nadir Gul
SKSerkan KÜÇÇÜKTÜRK
Serkan KÜÇÇÜKTÜRK
NKNadir Kocak
Nadir Kocak
The SARS-CoV-2 pandemic has led to major advances in mRNA vaccine development. This study aimed to develop a cationic lipid nanoparticle (LNP) coated mRNA vaccine targeting the receptor binding domain (RBD) against the SARS-CoV-2 virus and adding valine to the N-terminal end to increase its stability, and to comprehensively characterize the physical, thermal, microscopic and biological properties of vaccine. The vaccine was designed in silico and valine-added S-RBD molecule was generated by IVT. The LNP coated mRNA vaccine was evaluated by spectroscopic (UV–vis, FT-IR, Raman), thermodynamic (TGA/DSC), microscopic (STEM, AFM), size/potential (DLS) and surface tension analysis methods. The developed vaccine was analyzed for cytotoxicity (MTT) and pro/anti-inflammatory gene expression (qPCR). Spectroscopic analyses revealed distinct RNA and lipid peaks. Thermodynamic analyses revealed complete mass loss for mRNA and LNP at 136.2 °C and 85.7 °C, respectively. STEM analysis revealed that mRNA was uniformly coated with LNP, and its size was < 100 nm, and Ra/Rz values were 26.56/34.29 nm, respectively. Zeta potentials ranged from 0 to − 30 mV, and surface tensions were 33.8–38.0 mN/m, respectively. MTT analysis showed that the vaccine was not cytotoxic. qPCR analysis, significant increases were detected in IFNA1, IFNB1 and TNF gene expressions, but no significant increase was detected in IL6. Bioinformatic analyses revealed increased stability in mRNA structure and more robust pseudoknot formations after valine addition. Our study is the first study in which a uniquely designed valine-added mRNA vaccine coated with LNP targeting the RBD antigen of SARS-CoV-2 was developed and comprehensively characterized.

30 September 2022 in Journal of Contemporary Medicine
Verified
Journal Article
Closed access
PDF file
ŞÇşenol çitli
şenol çitli
NKNadir Koçak
Nadir Koçak
Background: Familial Mediterranean Fever (FMF) is an autoinflammatory disease and may express as various clinical findings. Chemokines are crucial elements of the inflammatory process. MCP-1 and its’ receptor CCR2 are the main chemokines for monocytes/macrophages that may play critical roles in FMF. Thus, it was aimed to investigate the MCP-1 (A-2518G) and CCR2 (G190A) polymorphisms and MCP-1 expression level, which may affect MEFV gene function. Material and Method: Patients with FMF were identified according to the Tel-Hashomer criteria. DNA and RNA were isolated from the obtained blood samples. Genotyping analysis was performed by PCR-RFLP technique. In addition, expression analyzes were performed by Real-time PCR method. The obtained results were evaluated statistically. Results: A total of 229 individuals (125 male and 104 female) were included in the study. While 120 individuals had FMF clinic, and 107 individuals did not have. The remaining two individuals had suspicious clinical status. In addition, while 75 individuals were homozygous mutants, 77 individuals were heterozygous mutants, and 77 individuals did not carry mutation in the MEFV gene. No significant relationship was found in between both FMF clinic and MEFV genotypes, and MCP-1 (A-2518G) and CCR2 (G190A) genotypes. In the expression analysis, MCP-1 expression increased in patients with FMF clinic compared to those without. In addition, MCP-1 expression was increased in the heterozygous MEFV group compared to those without mutation, moreover, the expression level was highest in homozygous MEFV group. In addition, according to the MCP-1 (A-2518G) genotyping, MCP-1 expression elevated in the homozygous as well as the heterozygous groups, compared to the Wild type group. Conclusion: MCP-1 expression is increased in FMF disease, which may explain the clinical differences between FMF patients. MEFV mutations may exacerbate inflammation by increasing MCP-1 transcription. MCP-1 expression is increased in patients with MCP-1(A-2518G) mutations, which aggravates FMF clinic. MCP-1 expression may be assessed as a marker in suspicious cases. Keywords: Familial Mediterranean Fever, MCP-1, CCR2, expression

3 June 2026
Verified
Book
Closed access
ATAli Torabi
Ali Torabi
NKNadir Koçak
Nadir Koçak
RTRukiye Tekdemir
Rukiye Tekdemir
ÖBÖzkan Bağci
Özkan Bağci
SNSüleyman Nergi̇z
Süleyman Nergi̇z
SGSara Rafiei Gavgani
Sara Rafiei Gavgani